S.G. Hymowitz - Concepedia

Author

S.G. Hymowitz

Also Known As

Hymowitz, Sarah G., P.A. McEwan, S G Hymowitz, S Hymowitz, S. G. Hymowitz, S. Hymowitz, S.G. Hymowitz, Sarah G. Hymowitz, Sarah G Hymowitz, Sarah G. Hymowitz

123

Publications

15.2K

Citations

H-Index

100

Concepts

All Affiliations

Genentech Molecular Oncology (United States)PDL BioPharma (United States)Genesys (United States)Gene Therapy Laboratory

About

S.G. Hymowitz is an author at Genentech specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	38	10.9K
2	Natural Sciences	16	16	1.7K
3	Engineering	4	4	537
4	Health Sciences	1	1	2.9K
5	Allergy	1	1	202

S.G. Hymowitz

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets Andrew J. Souers, Erwin R. Boghaert, Scott Ackler, Nature Medicine ThrombopoiesisThrombosisHematological MalignancyOncologyAntitumor Activity	2013	2.9K
Therapeutic antibody targeting of individual Notch receptors Yan Wu, Carol Cain-Hom, Lisa Choy, Nature ImmunologyReceptor (Biochemistry)ImmunochemistryAntibody EngineeringImmunotherapy	2010	710
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Klaus W. Wagner, Elizabeth A. Punnoose, Thomas Januario, Nature Medicine Cancer ResearchG Protein-coupled ReceptorMedicineApoptosisCell Death	2007	602
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding S.G. Hymowitz The EMBO Journal InflammationCytokineAutoimmune DiseaseImmunologyImmune Regulation	2001	553
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies Kim Newton, M Matsumoto, Ingrid E. Wertz, Cell Ubiquitin Chain EditingAutoimmune DiseaseImmunologyAutoimmunityAntibody Engineering	2008	550
Triggering Cell Death S.G. Hymowitz, Hans W. Christinger, Germaine Fuh, Molecular Cell ApoptosisCell DeathNecrosisMedicineCell Biology	1999	429
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation Anwesha Dey, Dhaya Seshasayee, Rajkumar Noubade, Science Hematological MalignancyCancer ResearchChromatinDe-ubiquitinating Enzyme Bap1Hereditary Cancer Syndrome	2012	416
K11-Linked Polyubiquitination in Cell Cycle Control Revealed by a K11 Linkage-Specific Antibody M Matsumoto, Katherine E. Wickliffe, Ken C. Dong, Molecular Cell ImmunogeneticsSignal TransductionCell RegulationCell DivisionImmunology	2010	381
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity Zhi‐Fu Tao, Lisa Hasvold, Le Wang, ACS Medicinal Chemistry Letters	2014	328
Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis Julie A. Di Paolo, Tao Huang, Mercedesz Balázs, Nature Chemical Biology InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseImmune Cell Development	2010	328

Page 1